Fuller,Smith&Turner PLC
01 August 2006
Fuller, Smith & Turner P.L.C. ("Fuller's" or the "Company").
Directors' and PDMR's interests in ordinary shares of the Company
Fullers announces that yesterday, the Trustees of its Long Term Incentive Plan
("LTIP") made a final release of shares to Directors and PDMRs in accordance
with the LTIP (grant number 3), which includes both listed "A" ordinary shares
of £1.00 each and unquoted "B" ordinary shares of 10p each.
To facilitate the financing of the resultant tax and National Insurance
liabilities arising on matched share awards, the Trustees have yesterday also
sold in the market on behalf of each Director and PDMR a proportion of the A
ordinary shares so awarded, at £12.46 per "A" ordinary share.
The table below sets out the details:
Director*/PDMR A shares sold A shares released B shares
released
P A Clarke* 149 445 1484
M Dally 45 135 452
S Emeny* 331 993 3312
R H F Fuller 101 303 1012
M L Gracie 197 589 1968
J Keeling 81 243 810
R J Roberts* 198 594 1982
M J Turner* 358 1072 3576
T J M Turner* 149 445 1484
1 August 2006
Enquiries: Marie Gracie, Company Secretary, 07956 559285
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.